Journal
GASTROENTEROLOGY CLINICS OF NORTH AMERICA
Volume 44, Issue 3, Pages 639-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.gtc.2015.05.010
Keywords
Gastric cancer; Helicobacter pylori; Elimination of gastric cancer; Eradication of Helicobacter pylori
Categories
Funding
- Eizai Co LTD at Hokkaido University Graduate School of Medicine
Ask authors/readers for more resources
Helicobacter pylori eradication therapy for chronic gastritis achieved world-first coverage by the Japanese national health insurance scheme in 2013, making a dramatic decrease of gastric cancer related deaths more realistic. Combining H pylori eradication therapy with endoscopic surveillance can prevent the development of gastric cancer. Even if it develops, most patients are likely to be diagnosed at an early stage, possibly resulting in fewer gastric cancer deaths. Success with the elimination of gastric cancer in Japan could lead other countries with a high incidence to consider a similar strategy, suggesting the potential for elimination of gastric cancer around the world.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available